(Q46873911)

26 December 2017

title

Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients (English)

1 reference

26 December 2017

author name string

Bayés B

1

1 reference

26 December 2017

Granada ML

2

1 reference

26 December 2017

Lauzurica R

3

1 reference

26 December 2017

Pastor MC

4

1 reference

26 December 2017

Navarro M

5

1 reference

26 December 2017

Bonet J

6

1 reference

26 December 2017

Llopis MA

7

1 reference

26 December 2017

Romero R

8

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

26 December 2017

Transplantation Proceedings

published in

1 reference

26 December 2017

volume

37

1 reference

26 December 2017

issue

9

1 reference

26 December 2017

page(s)

3808-3812

1 reference

26 December 2017

Impact of diabetes mellitus on kidney transplant recipients in Spain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

The effects of hyperlipidaemia on graft and patient outcome in renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Statin use after renal transplantation: a systematic quality review of trial-based evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Atorvastatin improves endothelial function in renal-transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Statins promote potent systemic antioxidant effects through specific inflammatory pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Does aggressive statin therapy offer improved cholesterol-independent benefits compared to conventional statin treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Association between adiponectin and mediators of inflammation in obese women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.08.064

10.1016/J.TRANSPROCEED.2005.08.064

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

16386546

1 reference

26 December 2017